Managing Dabigatran

The dabigatran App is designed for doctors to help them manage patients on the anticoagulant dabigatran. It will be useful to general practitioners, cardiologists, haematologists, neurologists, anaesthetists, emergency specialists and surgeons. In fact most clinicians will at some time have patients on anticoagulants and would find this App helpful.

The Dabigatran App will help you
• Select the right treatment for your patient.
• Provide safe advice if bleeding occurs including information about Idarucizumab
• Recommend when to stop treatment before surgery.
• Provide recommendations for managing emergency surgery
• Interpret coagulation results.

--------------------------------------------------------------------------
Features of the Dabigatran App

Dose recommendation
The Dabigatran App provides the correct dose for each indication with advice about possible dose changes in the presence of renal impairment

Drug information
Details of the common side-effects, potential drug interactions and basic pharmacology is immediately available.

Managing bleeding
Bleeding is a potential problem with any anticoagulant and can be complex to manage. The Dabigatran App provides advice about which treatments to use for both minor and major bleeding including when to use idarucizumab (Praxbind)

Managing surgery
A common question with any anticoagulant is how long should treatment be stopped before surgery? The Dabigatran App calculates a safe interval between stopping treatment and surgery by including renal function and the time since the last dose. It also offers advice for treatment prior to emergency surgery if the surgery cannot be delayed.

Interpreting coagulation results
Dabigatran prolongs several coagulation tests. The Dabigatran App combines the results of these tests to give an indication of the dabigtran plasma concentration.

Referenced information
All recommendations are linked to an information page which is appropriately referenced with links to the relevant publications.

Website for feedback
The Dabigatran App is linked to the Coagulation Conversation website to allow you to ask questions, provide feedback or even start a discussion.

We welcome all feedback.

----------------------------------------------------------------

The advice is based on published reviews and guidelines. Extensive efforts have been made to ensure the accuracy of the information however information may change for specific countries at short notice. The user should refer to the manufacturers datasheet for complete prescribing information.

Disclaimer
This software is to be used as a guide only and healthcare professionals should use clinical judgement and should individualise care for each patient. In no event shall the author or developer be liable to any party for damages resulting from the use of this application.

更新履歴
This app has been updated by Apple to display the Apple Watch app icon.

Information about the use of the reversal agent, Idarucizumab (Praxbind) for life-threatening or uncontrolled bleeding and emergency surgery.

Information about dabigatran assay.

Provides a link to our patients support website, Coagulation Conversation and our Facebook page